← Eichor
Condition: Hospital Acquired Pneumonia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hospital Acquired Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Phase 3 · 28 location(s) · Jena University Hospital · NCT06134492
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06841731
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotyp
Phase 3 · 26 location(s) · Nantes University Hospital · NCT06269900
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
NA · 2 location(s) · University Hospital Bispebjerg and Frederiksberg · NCT07189260
Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774
Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneu
NA · 5 location(s) · Nantes University Hospital · NCT06602934
Predictors and Outcomes of Ventilated Hospital-acquired Pneumonia
Phase N/A · 1 location(s) · Assiut University · NCT07667582
Nosocomial Respiratory Virus Infection
NA · 4 location(s) · Hospices Civils de Lyon · NCT06643039
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NA · 1 location(s) · Instituto de Assistencia Medica ao Servidor Publico Estadual · NCT05354778
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte
Phase N/A · 12 location(s) · Innoviva Specialty Therapeutics · NCT06746883
High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
NA · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT06170372
A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
Phase 2 · 6 location(s) · Omnix Medical Ltd · NCT06087536
A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07327619
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Phase 4 · 4 location(s) · National University of Singapore · NCT05979545
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clini
Phase N/A · 6 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06916481
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients W
Phase 3 · 1 location(s) · BioVersys SAS · NCT07326540
HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
NA · 4 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05952648
Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
Phase N/A · 2 location(s) · Sir Run Run Shaw Hospital · NCT07268560
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae I
NA · 15 location(s) · Southeast University, China · NCT06051513
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Phase N/A · 1 location(s) · Pfizer · NCT05733104
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766
Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients
NA · 1 location(s) · Assiut University · NCT06691399
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infecti
Phase 1 · 4 location(s) · Innoviva Specialty Therapeutics · NCT06801223
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infecti
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07089186
Nosocomial Pneumonia After Coronary Artery Bypass Grafting
Phase N/A · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT07476274
Optimising TREATment for Severe Gram-Negative Bacterial Infections
Phase 4 · 41 location(s) · National University of Singapore · NCT07004049
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.